# A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-trial-of-bevacizumab-an-anti-vascular-endothelial-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | James Chih‐Hsin Yang,Leah Haworth,Richard M. Sherry,Patrick Hwu,Douglas J. Schwartzentruber,Suzanne L. Topalian,Seth M. Steinberg,Helen X. Chen,Steven A. Rosenberg |
| Citations | 2,707 |
| DOI | 10.1056/nejmoa021491 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa021491?articleTools=true |
| OpenAlex ID | https://openalex.org/W2046507292 |
| PMID | 12890841 |
| Type | article |
| Year | 2003 |

## Paper authors

- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Seth M. Steinberg](https://scholariq.org/researchers/seth-m-steinberg/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.